Ironwood Pharmaceuticals Inc
- Last sale
- Nov 12, 2026 · -0.41%
- Market cap
- $801.27M
- 165.55M shares
- Filings
- 1,031
Q3 2026−15.7% FY25 yoy
Q3 2026+2,629.2% FY25 yoy
Q3 2026+5.8% FY25 yoy
FY 2025derived+22.8% FY25 yoy
Q3 2026+1,400.0% FY25 yoy
Q3 2026+143.3% FY25 yoy
- $801.27M
- 5.4×
- 2.0×
- —
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $296,151,000 | reported | |
| FY 2024 | 2024-12-31 | $351,410,000 | reported | |
| FY 2023 | 2023-12-31 | $442,735,000 | reported | |
| FY 2022 | 2022-12-31 | $410,596,000 | reported | |
| FY 2021 | 2021-12-31 | $413,753,000 | reported | |
| FY 2020 | 2020-12-31 | $389,523,000 | reported | |
| FY 2019 | 2019-12-31 | $428,413,000 | reported | |
| FY 2018 | 2018-12-31 | $346,639,000 | reported | |
| FY 2017 | 2017-12-31 | $298,276,000 | reported | |
| FY 2016 | 2016-12-31 | $273,957,000 | reported | |
| FY 2015 | 2015-12-31 | $149,555,000 | reported | |
| FY 2014 | 2014-12-31 | $76,436,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2022 | — | $126.39M | $126.39M | — | 154.16M sh | −3.2% | 46.2% |
| FY2021 | — | $24.13M | $24.13M | — | 159.22M sh | −1.1% | 9.2% |
Segments
Products
LineFY2025ShareChange
Collaborative arrangements revenue$296.15M100%−15.7%
Collaborative arrangement, other agreements$87.00K0.0%−88.1%
Product revenue, net———
Sale of active pharmaceutical ingredient———
Total$296.15M
Pharmaceutical preparations
Ironwood Pharmaceuticals Inc is the 68th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
CRMDCorMedix Inc.$311.7M617.0%52.3%$427.6MEOLSEvolus, Inc.$297.2M11.6%17.4%$475.2M
IRWDIronwood Pharmaceuticals Inc (this company)$296.2M15.7%8.1%$801.3M
RIGLRigel Pharmaceuticals Inc$294.3M64.1%124.7%$855.8MXERSXeris Biopharma Holdings, Inc.$291.8M43.7%0.2%$3.0BAUPHAurinia Pharmaceuticals Inc.$283.1M20.4%101.5%$2.2BHROWHarrow, Inc.$272.3M36.4%1.9%$1.1BVREOFVireo Growth Inc.$268.8M170.4%25.3%$379.7MLGNDLigand Pharmaceuticals Inc$268.1M60.4%46.4%$6.3BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR